Minerva Neurosciences
Nasdaq NERV · Burlington, MA
Minerva Neurosciences is a clinical trial sponsor based in Burlington, MA, listed as Nasdaq NERV. It has 1 active clinical trial with 380 planned participants. Since 2021 it has completed 2 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq NERV
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Minerva Neurosciences
Minerva Neurosciences is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 380 planned participants. Since 2021 it has completed 2 trials and stopped 0 early.
Minerva Neurosciences is based in Burlington, MA and is listed as Nasdaq NERV. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Minerva Neurosciences; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-28.
Approve Suite is not affiliated with Minerva Neurosciences.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.